Mark Fuerbach
About Mark Fuerbach
Mark Fuerbach is a Senior Institutional Sales professional specializing in cardiovascular products at Bristol-Myers Squibb in Tacoma, Washington, with over 18 years of experience in the company and extensive expertise in the pharmaceutical industry.
Current Role at Bristol-Myers Squibb
Mark Fuerbach serves as the Senior Institutional Sales in the Cardiovascular Division at Bristol-Myers Squibb. He is based in Tacoma, Washington, and has been with the company for over 18 years, starting in April 2005. In this role, Mark focuses on managing relationships and delivering business solutions to a diverse range of stakeholders, including medical professionals and C-suite executives. His expertise in cardiovascular therapeutic areas enables him to provide thorough product and disease state knowledge.
Previous Experience at Schwarz Pharma and La Haye Laboratories
Before joining Bristol-Myers Squibb, Mark Fuerbach held significant roles in the pharmaceutical industry. He worked at Schwarz Pharma for 11 years, from 1994 to 2005, where he served as a Pharmaceutical Sales and Regional Account Manager. Prior to that, he was a Pharmaceutical Sales Representative at La Haye Laboratories, a position he held for 4 years from 1990 to 1994. His extensive experience in these roles has contributed to his deep understanding of sales and marketing within the industry.
Educational Background
Mark Fuerbach studied Communication and Media Studies at Washington State University, earning a Bachelor of Arts (BA) degree. He attended the university from 1987 to 1989, where he acquired essential skills that have been instrumental in his professional journey in the healthcare marketplace.
Specialization in Cardiovascular Therapeutic Areas
Mark Fuerbach specializes in cardiovascular therapeutic areas, possessing detailed knowledge of products and disease states related to cardiovascular health. His role involves clinical education, performance improvement, and facilitating population health projects. Mark's work is focused on improving hospital therapeutic access management and developing value-based reimbursement strategies. He leverages health economic outcome data to inform discussions on the total cost of care.
Advocacy and Patient Access Programs
Mark Fuerbach is an advocate for health equity, actively involved in patient access programs. He engages in initiatives aimed at supporting underserved patients, ensuring they have better access to healthcare services. His efforts contribute to the overall mission of improving care and providing equitable healthcare solutions for those in need.